Cavitation Technologies, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
CVAT on OTC
Location
Chatsworth,, CA
Fiscal year end
30 June
Latest financial report
17 Feb 2026

Quick Takeaways

  • CVAT - Cavitation Technologies, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 885%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-606%</span>.
  • Most recent SEC facts end date: 13 Feb 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-02-13) highlights Return On Equity 884.9%, Return On Assets -310.2%, and Operating Margin -911.5%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

25.6/100

Weak Confidence high

Return On Equity

885%

Metric score 100.0/100

Return On Assets

-310%

Metric score 0.0/100

Financial Health

Current Ratio
0.29x
Quick Ratio
0.2x
Debt to Equity
-15.32x

Strengths

Return On Equity

Watchpoints

Return On Assets, Operating Margin, and Current Ratio

Key metrics snapshot

Profitability

Metric Latest value YoY change
Return On Equity 885% -606%
Return On Assets -310% -219%
Operating Margin -912% -6522%

Financial Health

Metric Latest value YoY change
Current Ratio 0.29x -75%
Quick Ratio 0.2x -82%
Debt-to-equity -15.32x +835%

Growth

Metric Latest value YoY change
Revenues YoY -90%
NetIncomeLoss YoY -213%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 309,720,740 +8.9%
Common Stock, Shares, Outstanding 309,720,740 +8.9%
Common Stock, Value, Issued $310,000 +9.2%
Weighted Average Number of Shares Outstanding, Basic 301,177,864 +5.9%
Weighted Average Number of Shares Outstanding, Diluted 301,177,864 +5.9%

Additional Metrics

Metric Latest value YoY change
Cost of Revenue $0 -100%
Research and Development Expense $82,000 +67%
General and Administrative Expense $1,208,000 +36%
Operating Income (Loss) $1,185,000 -769%
Earnings Per Share, Basic 0
Earnings Per Share, Diluted 0
Cash and Cash Equivalents, at Carrying Value $31,000 -95%
Accounts Receivable, after Allowance for Credit Loss, Current $0
Assets, Current $44,000 -94%
Assets $55,000 -92%
Liabilities, Current $153,000 -75%
Liabilities $303,000 -59%
Retained Earnings (Accumulated Deficit) $27,694,000 -4.5%
Stockholders' Equity Attributable to Parent $248,000 -978%
Liabilities and Equity $55,000 -92%
Common Stock, Shares Authorized 1,000,000,000 0%
Common Stock, Shares, Issued 309,720,740 +8.9%
Common Stock, Par or Stated Value Per Share 0.001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31,000 -95%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 10,000,000 0%
Additional Paid in Capital $27,136,000 +3.6%
Preferred Stock, Shares Outstanding 0
Interest Expense $14,000 0%
Preferred Stock, Par or Stated Value Per Share 0.001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY